Binghamton University researchers Investigate Proteins Linked to Pulmonary Hypertension
BINGHAMTON,NY – Pharmacy students and researchers at binghamton university are focusing on identifying proteins responsible for the progression of pulmonary hypertension,a rare and often fatal lung disease,with the goal of developing future drug therapies. The research, led by Assistant Professor Shen, is providing hands-on experience for students like Felix Aung, a P3 pharmacy student.
Aung’s primary duty is pinpointing proteins that drive the progression of pulmonary hypertension, possibly revealing targets for new medications. “Right now, one of my main responsibilities is to find proteins that are responsible for pulmonary hypertension progression. These proteins could be targets for future drug progress,” Aung said. He is also involved in data analysis, drafting potential publications, and collaborating with lab technicians.
The research offers students the chance to apply classroom learning to real-world scientific investigation. “I really enjoy doing hands-on work and being able to apply what I’ve learned in textbooks to basic science research,” Aung explained. He intends to pursue a career in cardiology and believes understanding disease pathology is crucial before medication is prescribed.Aung specifically expressed interest in idiopathic pulmonary arterial hypertension, noting, “As this disease is rarely studied and its mechanisms aren’t fully understood, it’s exciting for me to contribute to an area where there’s still a lot to uncover.”
assistant Professor Shen’s lab currently includes two technicians, one pharmacy student, and three undergraduate students. Research opportunities are available to qualified students at the undergraduate,master’s,and pharmacy levels.Shen also expressed a desire to expand collaborative research efforts with other institutions. “We also hope to initiate more collaborative research in the University and other institutions,” Shen said.
